Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
2.775
+0.225 (8.82%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $89.34 million as of April 24, 2025. Its market cap has decreased by -47.28% in one year.
Market Cap
89.34M
Enterprise Value
-69.24M
1-Year Change
-47.28%
Ranking
Category
Stock Price
$2.78
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $89.34M, a decrease of -74.82%. That is a compound annual growth rate of -54.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2025 | 82.10M | -43.33% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 389.05B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |